Stroke:风湿性疾病增加了卒中的风险

2016-02-27 MedSci MedSci原创

一些风湿性疾病与卒中有关。很少有人知道年龄与卒中亚型或风险之间的关联。研究人员量化了卒中,其亚型和风湿性疾病之间的联系,并确定了什么时候卒中的风险是最大的。研究人员检索了EMBASE(1980年)和MEDLINE(从开始)到2014年结束,风湿性疾病中卒中和卒中亚型的手动搜索参考表,以及通过磁共振成像测量脑血管疾病的研究。之前公布的荟萃分析和类风湿关节炎,系统性红斑狼疮,强直性脊柱炎,痛风以及牛皮

一些风湿性疾病与卒中有关。很少有人知道年龄与卒中亚型或风险之间的关联。研究人员量化了卒中,其亚型和风湿性疾病之间的联系,并确定了什么时候卒中的风险是最大的。

研究人员检索了EMBASE(1980年)和MEDLINE(从开始)到2014年结束,风湿性疾病中卒中和卒中亚型的手动搜索参考表,以及通过磁共振成像测量脑血管疾病的研究。

之前公布的荟萃分析和类风湿关节炎,系统性红斑狼疮,强直性脊柱炎,痛风以及牛皮癣显示在一般人群中卒中的风险过剩,比值比(OR)的范围从1.51(95%置信区间:1.39-1.62)到2.13(1.53-2.98)。在类风湿关节炎[缺血性:OR,1.64(1.32-2.05);出血性:OR,1.68(1.11-2.53)]和系统性红斑狼疮[缺血性:OR,2.11(1.66-2.67);出血性:OR,1.82(1.07-3.09)]卒中亚型的新的荟萃分析显示出在一般人群中卒中的风险过剩。风湿性疾病中卒中的风险在那些年龄<50岁最高中[OR,1.79(1.46-2.20)],并与随着年龄增加相对减少[>65岁:OR,1.14(0.94-1.38);差异P<0.007]。炎性关节病比非炎症性疾病(OR,1.3,1.2-1.3)有更高的卒中的风险。对于调整的风险因素或治疗的OR是不可能的。

大多数风湿性疾病患者比一般人群的卒中的风险都高,特别是<50岁的人群。相对于一般人群,类风湿关节炎和系统性红斑狼疮使得缺血性和出血性中风的风险增加60%到100%。

原始出处:

Wiseman SJ,Ralston SH,Wardlaw JM,et al.Cerebrovascular Disease in Rheumatic Diseases,Circulation,2016.2.25

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=67127, encodeId=d5fd6e12716, content=也许是风湿疾病治疗时使用的糖皮质激素呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160927/IMG57EA96AC605D49387.jpg, createdBy=7e381677945, createdName=Channel J, createdTime=Thu Mar 03 22:47:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66927, encodeId=54a86692e6a, content=内容新颖,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb51642483, createdName=cczlcxfa, createdTime=Wed Mar 02 23:21:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66562, encodeId=2cec66562f0, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:05:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361341, encodeId=447913613414b, content=<a href='/topic/show?id=15ac10083129' target=_blank style='color:#2F92EE;'>#风湿性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100831, encryptionId=15ac10083129, topicName=风湿性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Mon Feb 29 13:31:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66229, encodeId=40d36622939, content=风湿性疾病通过炎症机制参与动脉硬化, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Sun Feb 28 22:55:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2016-03-03 Channel J

    也许是风湿疾病治疗时使用的糖皮质激素呢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=67127, encodeId=d5fd6e12716, content=也许是风湿疾病治疗时使用的糖皮质激素呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160927/IMG57EA96AC605D49387.jpg, createdBy=7e381677945, createdName=Channel J, createdTime=Thu Mar 03 22:47:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66927, encodeId=54a86692e6a, content=内容新颖,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb51642483, createdName=cczlcxfa, createdTime=Wed Mar 02 23:21:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66562, encodeId=2cec66562f0, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:05:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361341, encodeId=447913613414b, content=<a href='/topic/show?id=15ac10083129' target=_blank style='color:#2F92EE;'>#风湿性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100831, encryptionId=15ac10083129, topicName=风湿性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Mon Feb 29 13:31:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66229, encodeId=40d36622939, content=风湿性疾病通过炎症机制参与动脉硬化, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Sun Feb 28 22:55:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2016-03-02 cczlcxfa

    内容新颖,学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=67127, encodeId=d5fd6e12716, content=也许是风湿疾病治疗时使用的糖皮质激素呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160927/IMG57EA96AC605D49387.jpg, createdBy=7e381677945, createdName=Channel J, createdTime=Thu Mar 03 22:47:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66927, encodeId=54a86692e6a, content=内容新颖,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb51642483, createdName=cczlcxfa, createdTime=Wed Mar 02 23:21:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66562, encodeId=2cec66562f0, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:05:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361341, encodeId=447913613414b, content=<a href='/topic/show?id=15ac10083129' target=_blank style='color:#2F92EE;'>#风湿性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100831, encryptionId=15ac10083129, topicName=风湿性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Mon Feb 29 13:31:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66229, encodeId=40d36622939, content=风湿性疾病通过炎症机制参与动脉硬化, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Sun Feb 28 22:55:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2016-03-01 破风4392

    原来如此

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=67127, encodeId=d5fd6e12716, content=也许是风湿疾病治疗时使用的糖皮质激素呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160927/IMG57EA96AC605D49387.jpg, createdBy=7e381677945, createdName=Channel J, createdTime=Thu Mar 03 22:47:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66927, encodeId=54a86692e6a, content=内容新颖,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb51642483, createdName=cczlcxfa, createdTime=Wed Mar 02 23:21:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66562, encodeId=2cec66562f0, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:05:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361341, encodeId=447913613414b, content=<a href='/topic/show?id=15ac10083129' target=_blank style='color:#2F92EE;'>#风湿性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100831, encryptionId=15ac10083129, topicName=风湿性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Mon Feb 29 13:31:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66229, encodeId=40d36622939, content=风湿性疾病通过炎症机制参与动脉硬化, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Sun Feb 28 22:55:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=67127, encodeId=d5fd6e12716, content=也许是风湿疾病治疗时使用的糖皮质激素呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160927/IMG57EA96AC605D49387.jpg, createdBy=7e381677945, createdName=Channel J, createdTime=Thu Mar 03 22:47:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66927, encodeId=54a86692e6a, content=内容新颖,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb51642483, createdName=cczlcxfa, createdTime=Wed Mar 02 23:21:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66562, encodeId=2cec66562f0, content=原来如此, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:05:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361341, encodeId=447913613414b, content=<a href='/topic/show?id=15ac10083129' target=_blank style='color:#2F92EE;'>#风湿性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100831, encryptionId=15ac10083129, topicName=风湿性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Mon Feb 29 13:31:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66229, encodeId=40d36622939, content=风湿性疾病通过炎症机制参与动脉硬化, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Sun Feb 28 22:55:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2016-02-28 chenchuny

    风湿性疾病通过炎症机制参与动脉硬化

    0

相关资讯

BMJ(评述):许多治疗风湿性疾病的药物会引发中性粒细胞减少症

尽管中性粒细胞减少症会使临床医生感到担忧,但Hay[1]等认为该发现并不重要并且通常不需要治疗。本文作者也认同此观点。下面将对Hay等的研究(Hay D, Hill M, Littlewood T. Neutropenia in primary care. BMJ 2014;349:g5340.)进行评论。由药物引起的中性粒细胞减少症在风湿性病人中很常见。我们承认在社区医疗中这是一个越来越严重的问

风湿病的艺术史

从中世纪起,在文艺复兴、巴洛克及后印象派等艺术领域的多个时期,艺术家们曾对包括RA、OA、屈曲指、颞动脉炎等在内的数种风湿病做出过清晰的描绘。而像皮埃尔-奥古斯特·雷诺阿、安东尼·高迪、劳尔·杜飞、保罗·克利、弗里达·卡罗、妮基·桑法勒等伟大的艺术家均饱受风湿性疾病如RA、硬皮病及慢性疼痛等困扰,是研究疾病如何影响对艺术家的观点、技巧及其作品内容的典例。 艺术是理解疾病自然进程的一大宝库